IL160475A0 - Combination products of aryl-substituted propanolamine derivatives with other active ingredients and the use thereof - Google Patents
Combination products of aryl-substituted propanolamine derivatives with other active ingredients and the use thereofInfo
- Publication number
- IL160475A0 IL160475A0 IL16047502A IL16047502A IL160475A0 IL 160475 A0 IL160475 A0 IL 160475A0 IL 16047502 A IL16047502 A IL 16047502A IL 16047502 A IL16047502 A IL 16047502A IL 160475 A0 IL160475 A0 IL 160475A0
- Authority
- IL
- Israel
- Prior art keywords
- aryl
- active ingredients
- combination products
- propanolamine derivatives
- substituted propanolamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10140170A DE10140170A1 (de) | 2001-08-22 | 2001-08-22 | Kombinationspräparate von arylsubstituierten Propanolaminderivaten mit weiteren Wirkstoffen und deren Verwendung |
| DE2001142455 DE10142455A1 (de) | 2001-08-31 | 2001-08-31 | Kombinationspräparate von arylsubstituierten Propanolderivaten mit weiteren Wirkstoffen und deren Verwendung |
| PCT/EP2002/008907 WO2003018059A2 (de) | 2001-08-22 | 2002-08-09 | Kombinationspräparate von arylsubstituierten propanolaminderivaten mit weiteren wirkstoffen und deren verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL160475A0 true IL160475A0 (en) | 2004-07-25 |
Family
ID=26009945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16047502A IL160475A0 (en) | 2001-08-22 | 2002-08-09 | Combination products of aryl-substituted propanolamine derivatives with other active ingredients and the use thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20030158094A1 (de) |
| EP (1) | EP1420826A2 (de) |
| JP (1) | JP2005505538A (de) |
| KR (1) | KR20040027963A (de) |
| CN (1) | CN1638801A (de) |
| AR (1) | AR035284A1 (de) |
| BR (1) | BR0211995A (de) |
| CA (1) | CA2457974A1 (de) |
| CO (1) | CO5560569A2 (de) |
| HR (1) | HRP20040172A2 (de) |
| HU (1) | HUP0401908A2 (de) |
| IL (1) | IL160475A0 (de) |
| MX (1) | MXPA04001256A (de) |
| NO (1) | NO20040726L (de) |
| NZ (1) | NZ531292A (de) |
| PA (1) | PA8553101A1 (de) |
| PE (1) | PE20030358A1 (de) |
| PL (1) | PL366855A1 (de) |
| RU (1) | RU2004108120A (de) |
| UY (1) | UY27418A1 (de) |
| WO (1) | WO2003018059A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
| WO2006023849A2 (en) | 2004-08-20 | 2006-03-02 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
| JP4990142B2 (ja) | 2004-08-23 | 2012-08-01 | マンカインド コーポレイション | 薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩 |
| IN2014DN09128A (de) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
| BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
| EP3281663B8 (de) | 2008-06-13 | 2022-09-21 | MannKind Corporation | Atemluftbetriebener trockenpulverinhalator zur verabreichung von medikamenten |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| BRPI0914308B8 (pt) | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
| TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| AU2011271097B2 (en) | 2010-06-21 | 2014-11-27 | Mannkind Corporation | Dry powder drug delivery system and methods |
| EP2694402B1 (de) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blisterverpackung für pharmakartuschen |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| CA2852536A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
| WO2014012069A2 (en) | 2012-07-12 | 2014-01-16 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| CA2918369C (en) | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023245A (en) * | 1987-11-10 | 1991-06-11 | Hauser-Kuhrts, Inc. | Improved niacin formulation |
| ES2223091T3 (es) * | 1997-04-04 | 2005-02-16 | Aventis Pharma Deutschland Gmbh | Derivados de propanolamina hipolipidemicos. |
| DE19845402B4 (de) * | 1998-10-02 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| DE19845406C2 (de) * | 1998-10-02 | 2001-10-18 | Aventis Pharma Gmbh | Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| DE19845405C2 (de) * | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
| NZ512532A (en) * | 1998-12-23 | 2003-12-19 | G | Combinations for treating cardiovascular diseases like hypercholesterolemia and atherosclerosis |
-
2002
- 2002-08-09 PL PL02366855A patent/PL366855A1/xx not_active Application Discontinuation
- 2002-08-09 KR KR10-2004-7002542A patent/KR20040027963A/ko not_active Application Discontinuation
- 2002-08-09 EP EP02796212A patent/EP1420826A2/de not_active Withdrawn
- 2002-08-09 CA CA002457974A patent/CA2457974A1/en not_active Abandoned
- 2002-08-09 HU HU0401908A patent/HUP0401908A2/hu unknown
- 2002-08-09 IL IL16047502A patent/IL160475A0/xx unknown
- 2002-08-09 MX MXPA04001256A patent/MXPA04001256A/es unknown
- 2002-08-09 RU RU2004108120/15A patent/RU2004108120A/ru not_active Application Discontinuation
- 2002-08-09 CN CNA028163532A patent/CN1638801A/zh active Pending
- 2002-08-09 NZ NZ531292A patent/NZ531292A/en unknown
- 2002-08-09 JP JP2003522574A patent/JP2005505538A/ja active Pending
- 2002-08-09 WO PCT/EP2002/008907 patent/WO2003018059A2/de active IP Right Grant
- 2002-08-09 BR BR0211995-1A patent/BR0211995A/pt not_active IP Right Cessation
- 2002-08-16 PE PE2002000744A patent/PE20030358A1/es not_active Application Discontinuation
- 2002-08-20 UY UY27418A patent/UY27418A1/es unknown
- 2002-08-20 PA PA20028553101A patent/PA8553101A1/es unknown
- 2002-08-20 AR ARP020103123A patent/AR035284A1/es not_active Application Discontinuation
- 2002-08-22 US US10/225,802 patent/US20030158094A1/en not_active Abandoned
-
2004
- 2004-02-19 CO CO04014409A patent/CO5560569A2/es not_active Application Discontinuation
- 2004-02-19 NO NO20040726A patent/NO20040726L/no not_active Application Discontinuation
- 2004-02-20 HR HR20040172A patent/HRP20040172A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003018059A2 (de) | 2003-03-06 |
| CN1638801A (zh) | 2005-07-13 |
| KR20040027963A (ko) | 2004-04-01 |
| NO20040726L (no) | 2004-02-19 |
| CA2457974A1 (en) | 2003-03-06 |
| HUP0401908A2 (hu) | 2005-01-28 |
| AR035284A1 (es) | 2004-05-05 |
| PL366855A1 (en) | 2005-02-07 |
| HRP20040172A2 (en) | 2004-10-31 |
| EP1420826A2 (de) | 2004-05-26 |
| PE20030358A1 (es) | 2003-04-23 |
| JP2005505538A (ja) | 2005-02-24 |
| CO5560569A2 (es) | 2005-09-30 |
| RU2004108120A (ru) | 2005-04-10 |
| US20030158094A1 (en) | 2003-08-21 |
| BR0211995A (pt) | 2004-09-28 |
| NZ531292A (en) | 2005-08-26 |
| PA8553101A1 (es) | 2003-06-30 |
| MXPA04001256A (es) | 2004-05-27 |
| UY27418A1 (es) | 2002-11-29 |
| WO2003018059A3 (de) | 2003-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL158076A0 (en) | Benzamidine derivatives and pharmaceutical compositions containing the same | |
| IL155071A0 (en) | Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same | |
| HUP0301146A3 (en) | 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use | |
| IL160475A0 (en) | Combination products of aryl-substituted propanolamine derivatives with other active ingredients and the use thereof | |
| IL160716A0 (en) | Aryl-substituted pyridinecarboxamide derivatives and pharmaceutical compositions containing the same | |
| IL161616A0 (en) | Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| IL158499A (en) | Malononitrile compounds and their use in the manufacture of pesticide compositions | |
| IL155196A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
| IL158044A0 (en) | Cyclopropylindole derivatives and pharmaceutical compositions containing the same | |
| IL158300A0 (en) | Bisarylimidazol derivatives and pharmaceutical compositions containing the same | |
| IL159086A0 (en) | 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same | |
| IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
| AU3680300A (en) | Sucralose-containing composition and eatable product comprising the same | |
| IL158523A0 (en) | Epothilone derivatives and pharmaceutical compositions containing the same | |
| IL156812A0 (en) | Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same | |
| EP1419785A4 (de) | Arzneimittel mit einem chymase-hemmer und einem ace-hemmer als wirkstoffe | |
| AU2002328494A1 (en) | Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients | |
| IL164022A0 (en) | Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same | |
| AU2002345255A1 (en) | Composition comprising soy and use thereof in the prevention and/or treatment of various diseases | |
| HUP0300917A3 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them | |
| GB0108470D0 (en) | Pharmaceutical compositions and their use | |
| HK1057676A1 (en) | Egg-based powder and food containing the same | |
| IL160474A0 (en) | Combination products of 1,4-benzothiepine 1,1-dioxide derivatives with other active ingredients and the use thereof | |
| SI1499729T1 (sl) | Derivati encima ki inducira nf-kappab njihova priprava in uporaba | |
| HUP0401484A3 (en) | Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine and pharmaceutical compositions containing the combination |